SciLifeLab DDLS and GMS part of two new national projects
Genomic Medicine Sweden (GMS) and the SciLifeLab & Wallenberg National Program for Data-Driven Life Science (DDLS), together with other key partners, are involved in two new projects to make data available for research and development in the precision medicine area. The projects “System Demonstrator for National Accessibility of Omics Data for Healthcare, Research, and Innovation” and “Scalable National Data Sharing of Omics Data for Healthcare, Research, and Innovation” will further increase the precision medicine capabilities in Sweden and connect key players to form a unique data ecosystem.
These two projects address crucial aspects of data sharing, innovation, healthcare, and research. They hold the potential to significantly influence and advance precision medicine.
“This financing allows us at SciLifeLab to work together with GSM, industry, government authorities, patient organizations and healthcare regions across the country to make valuable data accessible for research and shorten the path to use SciLifeLab developed methods at hospitals. This is key for generating new knowledge and innovation to keep Sweden in forefront of precision medicine,” says Janne Lehtiö, area Lead on the Precision Medicine area on the SciLifeLab & Wallenberg National Program for Data-Driven Life Science.
Scalable National Data Sharing of Omics Data for Healthcare, Research, and Innovation
The emergence of precision medicine has made the sharing of health data increasingly important for healthcare, academia, and innovation by pulling research closer to clinical routine. The project is structured to take the remaining steps towards concrete data sharing nationally between the National Genomics Platform (NGP), established by Genomic Medicine Sweden (GMS), and four central players in Swedish life science: healthcare-related entities in the form of Regional Cancer Centers in collaboration (RCC) and the Public Health Agency of Sweden (Fohm), the research community in the form of the Data-Driven Life Science (DDLS) program within SciLifeLab, as well as research-oriented pharmaceutical companies through Lif.
The project is granted within the SWElife call for strategic projects in 2023.
System Demonstrator for National Accessibility of Omics Data for Healthcare, Research, and Innovation
The application aims to demonstrate on a large scale how Swedish healthcare, through a systemic change in the collection and accessibility of advanced molecular data, such as omics data, enables the accelerated implementation of precision medicine in healthcare and creates new opportunities for research and innovation. The proposed system demonstrator intends to fundamentally transform data national genomics flows supporting clinical diagnostics and research by developing and implementing the National Genomics Platform (NGP) within Genomic Medicine Sweden (GMS) and connecting that with DDLS. The project will drive value-added work through data structuring and standardization, deeper collaboration with research data infrastructure at SciLifeLab, and making data accessible nationally and internationally for academia, authorities, and industry.
“We depend on joint development of good data management practices across our organizations to increase our ability to link molecular and clinical data across Sweden for future cutting-edge precision medicine research and for clinical implementation,” says Päivi Östling, SciLifeLab Precision Medicine Capability Lead.
Vinnova communicated that the projects awarded this year will provide better opportunities for care to make the correct diagnosis early, make it easier to overview a patient’s medical history and facilitate faster progress in research.
“Being able to collaborate and contribute to the new projects will greatly improve the possibilities of the DDLS Data Science Node in Precision Medicine and Diagnostics to provide tailored and necessary support to the research community,” concludes KI Compliance & Data Office (CDO) Lead Cecilia Martinsson Björkdahl.
